BHVN - Biohaven Ltd.

Day 1m 10m 60m PreMarket Market AfterHours Gap
9.5 0.25 (2.63%) -0.01 (-0.1%) 0.02 (0.21%) -0.2 (-2.01%) 0.22 (2.32%) 0.11 (1.14%) 0.07 (0.73%) 0.14 (1.46%)

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-1.94
Diluted EPS:
-1.94
Basic P/E:
-5.0258
Diluted P/E:
-5.0258
RSI(14) 1m:
31.41
VWAP:
9.75
RVol:

Events

Period Kind Movement Occurred At

Related News